Correspondence 0001104659-24-092984 from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: Aug. 26, 2024 · CIK: 0001130598 · Accession: 0001104659-24-092984
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280642
Letter
Traws Pharma, Inc.
12 Penns Trail
Newtown, PA 18940
August 26, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Gama and Laura Crotty
Re: Traws Pharma, Inc.
Registration Statement on Form S-3
Filed July 1, 2024
File No. 333-280642
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Traws Pharma, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on August 28, 2024, or as soon as practicable thereafter.
TRAWS PHARMA, INC.
By: /s/ MARK GUERIN
Name: Mark Guerin
Title: Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm Traws Pharma, Inc. 12 Penns Trail Newtown, PA 18940 August 26, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Doris Gama and Laura Crotty Re: Traws Pharma, Inc. Registration Statement on Form S-3 Filed July 1, 2024 File No. 333-280642 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Traws Pharma, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on August 28, 2024, or as soon as practicable thereafter. TRAWS PHARMA, INC. By: /s/ MARK GUERIN Name: Mark Guerin Title: Chief Financial Officer